Insider · CIK 0002012715
Sanjay Nayak
Files at OCUL (OCULAR THERAPEUTIX, INC). First filing Nov 27, 2024, latest Feb 25, 2026.
Sanjay Nayak files SEC Form 4 as officer at OCUL (OCULAR THERAPEUTIX, INC). Since Nov 27, 2024, Sanjay Nayak has reported 0 open-market buys worth $0 and 6 open-market sells worth $183k, the latest filed on Feb 25, 2026.
A track record needs three past buys with six months of prices behind them; Sanjay Nayak has 0, so none is measured yet.
The newest scored trade: sold $15k of OCUL on Feb 23, 2026, filed Feb 25, 2026, scored 10 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $131k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OCUL: OCULAR THERAPEUTIX, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | OCULAR THERAPEUTIX, INC | $15k 1,759 shares | -1% | +42% from low-48% from high | |
| 20Weak | OCULAR THERAPEUTIX, INC | $94k 10,348 shares | -3% | +53% from low-44% from high | |
| 10Weak | OCULAR THERAPEUTIX, INC | $23k 1,878 shares | -1% | +104% from low-11% from high | |
| 10Weak | OCULAR THERAPEUTIX, INC | $23k 1,885 shares | -1% | +100% from low-6% from high | |
| 10Weak | OCULAR THERAPEUTIX, INC | $13k 1,862 shares | -1% | +23% from low-36% from high | |
| 10Weak | OCULAR THERAPEUTIX, INC | $16k 1,814 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 24, 2025 | OCUL OCULAR THERAPEUTIX, INC. | 1,878 0.00% of outstanding | $23k | Nov 24, 2025 | $23k |
| Aug 25, 2025 | OCUL OCULAR THERAPEUTIX, INC. | 1,885 0.00% of outstanding | $23k | Aug 25, 2025 | none |
| May 23, 2025 | OCUL OCULAR THERAPEUTIX, INC. | 1,862 0.00% of outstanding | $13k | May 23, 2025 | $13k |
| Feb 24, 2025 | OCUL OCULAR THERAPEUTIX, INC. | 1,895 0.00% of outstanding | $13k | Feb 24, 2025 | $16k |
| Nov 25, 2024 | OCUL OCULAR THERAPEUTIX, INC. | 1,814 0.00% of outstanding | $16k | Nov 25, 2024 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -1,759 | $8.28 | $15k | 330,653 | Feb 25, 2026 |
| Feb 12, 2026 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -10,348 | $9.04 | $94k | 332,412 | Feb 17, 2026 |
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Common Stock | +64,900 | $0.00 | $0 | 342,760 | Jan 6, 2026 |
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Stock Option (Right to Buy)derivative | +197,650 | $0.00 | $0 | 197,650 | Jan 6, 2026 |
| Nov 24, 2025 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -1,878 | $12.04 | $23k | 277,860 | Nov 26, 2025 |
| Aug 25, 2025 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -1,885 | $12.04 | $23k | 279,738 | Aug 27, 2025 |
| May 23, 2025 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -1,862 | $7.17 | $13k | 281,623 | May 27, 2025 |
| Nov 25, 2024 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -1,814 | $9.00 | $16k | 174,380 | Nov 27, 2024 |
Questions about Sanjay Nayak
Answered from the filings on this page, as of the latest one.
Is Sanjay Nayak buying or selling?
In the last 12 months Sanjay Nayak reported 0 open-market buys worth $0 and 3 open-market sells worth $131k on SEC Form 4; the latest was sold $15k of OCUL on Feb 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Sanjay Nayak's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sanjay Nayak has 0.
Where does Sanjay Nayak file Form 4?
Sanjay Nayak has filed Form 4 at OCUL (OCULAR THERAPEUTIX, INC) as Chief Strategy Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.